Education
About Us
Working with TipRanks
Follow Us
Exicure (XCUR)
:XCUR
XCUR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.44 - $36.00
Previous CloseN/A
Volume39.94K
Average Volume (3M)39.74K
Market Cap
$88.39M
Enterprise Value$75.81M
Total Cash (Recent Filing)$26.27M
Total Debt (Recent Filing)$4.92M
Price to Earnings (P/E)―
Beta2.71
Next Earnings
May 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.59
Shares Outstanding6,317,771
10 Day Avg. Volume21,659
30 Day Avg. Volume39,740
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)104.31
Price to Cash Flow (P/CF)-26.30
P/FCF Ratio0.00
Enterprise Value/Market Cap0.86
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-53.28
Enterprise Value/Ebitda-23.90
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Exicure News
PremiumCompany Announcements
Exicure Secures $8.7 Million in Stock Purchase Deal---
Ownership Overview
32.60% Insiders
0.55% Mutual Funds
10.81% Other Institutional Investors
55.36% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
XCUR FAQ
What was Exicure’s price range in the past 12 months?
Exicure lowest stock price was $1.44 and its highest was $36.00 in the past 12 months.
What is Exicure’s market cap?
Exicure’s market cap is $88.39M.
When is Exicure’s upcoming earnings report date?
Exicure’s upcoming earnings report date is May 07, 2025 which is in 37 days.
How were Exicure’s earnings last quarter?
Exicure released its earnings results on Mar 18, 2025. The company reported -$1.192 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.192.
Is Exicure overvalued?
According to Wall Street analysts Exicure’s price is currently Overvalued.
Does Exicure pay dividends?
Exicure does not currently pay dividends.
What is Exicure’s EPS estimate?
Exicure’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Exicure have?
Exicure has 6,317,771 shares outstanding.
What happened to Exicure’s price movement after its last earnings report?
Exicure reported an EPS of -$1.192 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.032%.
Which hedge fund is a major shareholder of Exicure?
Currently, no hedge funds are holding shares in XCUR
---
Exicure Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 22.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $8.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 3.7%
Last 30 Days ▲ 2.4%
Last 30 Days ▲ 2.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
365.24%
12-Months-Change
Fundamentals
Return on Equity
-197.92%
Trailing 12-Months
Asset Growth
30.02%
Trailing 12-Months
Company Description
Exicure
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
---
XCUR Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Alnylam Pharma
―
Arrowhead Pharmaceuticals
―
Ionis Pharmaceuticals
―
Sorrento Therapeutics
―
Moderna
―
---